Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial (Nature Medicine, (2021), 27, 9, (1536-1543), 10.1038/s41591-021-01444-0)

Hai Qiang Mai, Qiu Yan Chen, Dongping Chen, Chaosu Hu, Kunyu Yang, Jiyu Wen, Jingao Li, Ying Rui Shi, Feng Jin, Ruilian Xu, Jianji Pan, Shenhong Qu, Ping Li, Chunhong Hu, Yi Chun Liu, Yi Jiang, Xia He, Hung Ming Wang, Wan Teck Lim, Wangjun LiaoXiaohui He, Xiaozhong Chen, Zhigang Liu, Xianglin Yuan, Qi Li, Xiaoyan Lin, Shanghua Jing, Yanju Chen, Yin Lu, Ching Yun Hsieh, Muh Hwa Yang, Chia Jui Yen, Jens Samol, Hui Feng, Sheng Yao, Patricia Keegan, Rui Hua Xu*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

3 Scopus citations

Fingerprint

Dive into the research topics of 'Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial (Nature Medicine, (2021), 27, 9, (1536-1543), 10.1038/s41591-021-01444-0)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology